The importance of considering different healthcare settings when estimating the burden of clostridium difficile

Clinical Infectious Diseases

Volumn 60, Issue 6, 2015, Pages 831-836

  Kuntz, Jennifer L ^a   Polgreen, Philip M ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Clostridium difficile; Incidence; Surveillance

Indexed keywords

AMBULATORY CARE; ARTICLE; COMMUNITY CARE; E-MAIL; EMERGENCY WARD; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN RELATION; NONHUMAN; OUTPATIENT; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; RECURRENT INFECTION; TELEPHONE; ADULT; CLOSTRIDIUM INFECTIONS; FEMALE; HEALTH CARE DELIVERY; INCIDENCE; MALE; PATHOGENICITY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME;

ADULT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DELIVERY OF HEALTH CARE; ELECTRONIC MAIL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INPATIENTS; MALE; OUTPATIENTS; POPULATION SURVEILLANCE; TELEPHONE; TIME FACTORS;

EID: 84936107665     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu955     Document Type: Article

References (34)

1. Elixhauser A, Jhung M. Clostridium difficile-Associated Disease in U.S. Hospitals, 1993-2005: Statistical Brief #50. Rockville, MD: Agency for Health Care Policy and Research, 2006.
2. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14:929-31.
3. Centers for Disease Control and Prevention. Severe Clostridium difficileassociated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1201-5.
4. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:340-3.
5. Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 2005; 26:680-4.
6. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A casecontrol study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62:388-96.
7. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study. BMC Infect Dis 2011; 11:194.
8. Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol 2014; 30:54-62.
9. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012; 61:157-62.
10. Byrne JM, Elliott S, Firek A. Initial experience with patient-clinician secure messaging at a VA medical center. J Am Med Inform Assoc 2009; 16:267-70.
11. Cook KE, Ludens GM, Ghosh AK, Mundell WC, Fleming KC, Majka AJ. Improving efficiency and reducing administrative burden through electronic communication. Perm J 2013; 17:26-30.
12. Hassol A, Walker JM, Kidder D, et al. Patient experiences and attitudes about access to a patient electronic health care record and linked web messaging. J Am Med Inform Assoc 2004; 11:505-13.
13. Walsh C, Siegler EL, Cheston E, et al. Provider-to-provider electronic communication in the era of meaningful use: A review of the evidence. J Hosp Med 2013; 8:589-97.
14. Wallwiener M, Wallwiener CW, Kansy JK, Seeger H, Rajab TK. Impact of electronic messaging on the patient-physician interaction. J Telemed Telecare 2009; 15:243-50.
15. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5.
16. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ 2004; 171:466-72.
17. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-15.
18. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23:653-9.
19. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. U.S. Department of Health and Human Services, 2013. Available at: http://www.cdc.gov/drugresistance/threatreport-2013/. Accessed 24 September 2013.
20. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013; 173:1359-67.
21. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007; 142:624-31.
22. Halabi WJ, Nguyen VQ, Carmichael JC, Pigazzi A, Stamos MJ, Mills S. Clostridium difficile colitis in the United States: A decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy. J Am Coll Surg 2013; 217:802-12.
23. Zilberberg MD, Shorr AF, Kollef MH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis 2008; 14:1756-8.
24. Kuntz JL, Johnson ES, Raebel MA, et al. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol 2012; 33: 1031-8.
25. Price MF, Dao-Tran T, Garey KW, et al. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 2007; 65:42-6.
26. Dubberke ER, McMullen KM, Mayfield JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track communityonset disease? Infect Control Hosp Epidemiol 2009; 30:332-7.
27. Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis 2010; 16:197-204.
28. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 1998; 26:141-5.
29. Hu SS, Balluz L, Battaglia MP, Frankel MR. The impact of cell phones on public health surveillance. Bull World Health Organ 2010; 88:799.
30. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173:2039-46.
31. Guillemin I, Marrel A, Lambert J, et al. Patients' experience and perception of hospital-treated Clostridium difficile infections: A qualitative study. Patient 2014; 7:97-105.
32. Madeo M, Boyack M. Using the lived experiences of patients with Clostridium difficile infection to improve care. Nurs Times 2010; 106:10-3.
33. Agency for Healthcare Research and Quality. HCUPnet, Healthcare Cost and Utilization Project. Rockville, MD, 2014.
34. Polgreen PM, Yang M, Kuntz JL, Laxminarayan R, Cavanaugh JE. Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: A spatial and time series analysis. Infect Control Hosp Epidemiol 2011; 32:723-6.